95 related articles for article (PubMed ID: 16377152)
1. Active control trials: endpoints beyond conventional efficacy and tolerability measures.
Perucca E
Epilepsy Res; 2006 Jan; 68(1):73-4. PubMed ID: 16377152
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality-of-life issues: optimizing patient outcomes.
Baker GA
Neurology; 1995 Mar; 45(3 Suppl 2):S29-34. PubMed ID: 7898743
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in adolescents with epilepsy assessed with a measure for adults.
Stevanovic D
Acta Neurol Scand; 2008 Nov; 118(5):343; discussion 343. PubMed ID: 18462477
[No Abstract] [Full Text] [Related]
4. Active control comparisons: the ideal trial design.
Brodie MJ; Whitehead J
Epilepsy Res; 2006 Jan; 68(1):69-73. PubMed ID: 16377147
[TBL] [Abstract][Full Text] [Related]
5. Monotherapy in adults and elderly persons.
Faught E
Neurology; 2007 Dec; 69(24 Suppl 3):S3-9. PubMed ID: 18071156
[TBL] [Abstract][Full Text] [Related]
6. Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients.
Park SP; Hwang YH; Lee HW; Suh CK; Kwon SH; Lee BI
Epilepsy Behav; 2008 Jan; 12(1):102-8. PubMed ID: 17945539
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
Perry MS; Benatar M
Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
[TBL] [Abstract][Full Text] [Related]
8. Proof of Principle studies.
Schmidt B
Epilepsy Res; 2006 Jan; 68(1):48-52. PubMed ID: 16377153
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Holloway RG
Neurology; 2005 Jan; 64(1):172-4; author reply 172-4. PubMed ID: 15642936
[No Abstract] [Full Text] [Related]
10. The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy.
Wesnes KA; Edgar C; Dean AD; Wroe SJ
Epilepsy Behav; 2009 Mar; 14(3):522-8. PubMed ID: 19111629
[TBL] [Abstract][Full Text] [Related]
11. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
[TBL] [Abstract][Full Text] [Related]
12. Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study).
Lossius MI; Hessen E; Mowinckel P; Stavem K; Erikssen J; Gulbrandsen P; Gjerstad L
Epilepsia; 2008 Mar; 49(3):455-63. PubMed ID: 17888074
[TBL] [Abstract][Full Text] [Related]
13. Monotherapy trials: endpoints.
Mattson RH
Epilepsy Res; 2001 May; 45(1-3):109-17; discussion 119, 121-2. PubMed ID: 11461809
[TBL] [Abstract][Full Text] [Related]
14. Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy.
Jakovljevic MB; Jankovic SM; Jankovic SV; Todorovic N
Epilepsy Res; 2008 Aug; 80(2-3):180-3. PubMed ID: 18495431
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs.
Kanner AM; Gidal BE
Int Rev Neurobiol; 2008; 83():397-416. PubMed ID: 18929094
[TBL] [Abstract][Full Text] [Related]
16. The treatment of the first seizure: the risks.
Perucca E
Epilepsia; 2008; 49 Suppl 1():29-34. PubMed ID: 18184152
[TBL] [Abstract][Full Text] [Related]
17. Monotherapy clinical trial design.
Sachdeo R
Neurology; 2007 Dec; 69(24 Suppl 3):S23-7. PubMed ID: 18071154
[TBL] [Abstract][Full Text] [Related]
18. Antiepileptic drug treatment in children.
Hadjiloizou SM; Bourgeois BF
Expert Rev Neurother; 2007 Feb; 7(2):179-93. PubMed ID: 17286551
[TBL] [Abstract][Full Text] [Related]
19. [Antiepileptic drugs as mood stabilizers: what did we learn from the epileptology?].
Rajna P
Ideggyogy Sz; 2008 Sep; 61(9-10):305-16. PubMed ID: 18841650
[TBL] [Abstract][Full Text] [Related]
20. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study.
López-Góngora M; Martínez-Domeño A; García C; Escartín A
Epileptic Disord; 2008 Dec; 10(4):297-305. PubMed ID: 19017572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
